Elevation Oncology Inc. Contingent Value Right
13F holders, Q4 2025 (December 31)1holders
0new positions
0sold out
$0.00avg. 13F price*
At the end of Q4 2025, 1 institutions reported holding Elevation Oncology Inc. Contingent Value Right in their 13F filings, unchanged from Q3 2025. 0 opened new positions and 0 sold out. The largest holder was Archer Investment Corp ($0).
- Company
- Elevation Oncology Inc. Contingent Value Right
- CUSIP
- 286CVR022
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 1 holders
| Archer Investment Corp | 0.00% | No change | 1,298 | $0 |
"% of holder's portfolio" is ELEVATION ONCOLOGY INC CONTINGENT VALUE RIGHT's weight in each manager's 13F, not the share of Elevation Oncology Inc. Contingent Value Right the manager owns.